Oncolytics Biotech Inc
ONCY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001129928
No open-market purchases or sales by Oncolytics Biotech Inc insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $3.76M in total; no superinvestor holds it.
Holders of 5% or more of ONCY
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Oncolytics Biotech Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Anson Funds Management LP | 13G/A | 7.00%7.65M shares | −2.60 ppfrom 9.60% | Feb 14, 20252 filings | Nov 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Oncolytics Biotech Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 20253:05 PM ET | Anson Funds Management LPand 5 others | 13G/A | 7.00%7.65M shares | −2.60 ppfrom 9.60% | Sep 30, 2025 | SEC |
| Feb 14, 20256:30 PM ET | Anson Funds Management LPand 5 others | 13G | 9.60%8.19M shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Oncolytics Biotech Inc shares.
No Form 144 notices for Oncolytics Biotech Inc are on file.